Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| ITGRInteger Holdings Corp | $4.3B | 34.5× | $1.85B | +8.0% | $102.81M | $21.38M | $1.36B | Fair valued |
| UCBUnited Community Banks Inc | $4.3B | 11.7× | $1.06B | +11.7% | $328.1M | $455.1M | $380.6M | Fair valued |
| ARXAccelerant Holdings | $4.3B | — | $912.9M | +51.5% | -$1.35B | $1.57B | $120.1M | Fair valued |
| TCBITexas Capital Bancshares Inc | $4.29B | 12.8× | $1.26B | +34.7% | $330.24M | $3.7B | $350M | Fair valued |
| HTFLHeartflow, Inc. | $4.28B | — | $176.03M | +39.9% | -$116.79M | $34.36M | $27.13M | Overvalued |
| TKCTurkcell Iletisim Hizmetleri A S | $4.27B | 9.8× | TRY 107.12B | +14.6% | TRY 12.53B | TRY 49.98B | TRY 86.51B | Undervalued |
| SLGSl Green Realty Corp | $4.27B | — | $1B | +13.2% | -$96.91M | $143.87M | $959.66M | Fair valued |
| AMLXAmylyx Pharmaceuticals, Inc. | $4.27B | — | $0 | -100.0% | -$144.74M | $49.33M | $5.26M | Fair valued |
| BRCBrady Corp | $4.26B | 21.0× | $1.66B | +9.8% | $205.38M | $187.15M | $83.59M | Fair valued |
| RUMRUM Group Inc. | $4.24B | — | $100.62M | +5.4% | -$81.83M | $203.27M | $142.96M | Overvalued |
| KLICKulicke & Soffa Industries Inc | $4.23B | 37.1× | $654.08M | -7.4% | $213K | $368.57M | $38.12M | Fair valued |
| CCCCCC Intelligent Solutions Holdings Inc. | $4.23B | 101.8× | $1.06B | +11.9% | $1.69M | $115.86M | $1.33B | Fair valued |
| BFHBread Financial Holdings, Inc. | $4.23B | 8.6× | $3.85B | +0.2% | $518M | $3.68B | $4.39B | Undervalued |
| VEONVEON Ltd. | $4.22B | 85.1× | $4.4B | +9.9% | $591M | $1.73B | $3.14B | Undervalued |
| MIRMirion Technologies, Inc. | $4.22B | 192.3× | $925.4M | +7.5% | $28.8M | $418.7M | $476.6M | Overvalued |
| AKO-AAndina Bottling Co Inc | $4.22B | 12.1× | CLP 3.34T | +3.7% | CLP 270.48B | CLP 296.54B | CLP 75M | Undervalued |
| AZZAzz Inc | $4.22B | 21.4× | $1.65B | +4.6% | $317.26M | $1.06M | $542.82M | Fair valued |
| LEGNLegend Biotech Corp | $4.21B | — | $1.03B | +64.0% | -$296.8M | $901.9M | $413.7M | Undervalued |
| FCNFti Consulting, Inc | $4.2B | 18.4× | $3.79B | +2.4% | $270.87M | $163.75M | $1.27B | Fair valued |
| CATYCathay General Bancorp | $4.2B | 12.3× | $817.89M | +12.1% | $315.12M | $1.33B | $154.25M | Fair valued |